An Update on Twenty Years of Anemia Management with Erythropoiesis-Stimulating Agents in Nephrology and Oncology/Hematology

被引：7
|
作者：
Aapro, Matti [1 ]
机构：
[1] Multidisciplinary Oncol Inst, Genolier, Switzerland
来源：
ONCOLOGIST | 2009年 / 14卷
关键词：
Anemia; Erythropoiesis stimulating agents; Erythropoietin; Nephrology; Oncology; Hematology; QUALITY-OF-LIFE; EPOETIN-ALPHA; CANCER-PATIENTS; HEMOGLOBIN LEVEL; EORTC GUIDELINES; INTRAVENOUS IRON; DOUBLE-BLIND; CHEMOTHERAPY; RECEPTOR; PROLIFERATION;
D O I：
10.1634/theoncologist.2009-S1-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 5
页数：5
相关论文
共 50 条
  • [31] Erythropoiesis-stimulating agents (ESAs): Do they still have a role in chemotherapy-induced anemia (CIA)?
    Bormanis, Janis
    Quirt, Ian
    Chang, Jose
    Kouroukis, C. Tom
    MacDonald, David
    Melosky, Barb
    Verma, Sunil
    Couture, Felix
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 87 (02) : 132 - 139
  • [32] Impact of Erythropoiesis-Stimulating Agents on Energy and Physical Function in Nondialysis CKD Patients With Anemia: A Systematic Review
    Gandra, Shravanthi R.
    Finkelstein, Fredric O.
    Bennett, Antonia V.
    Lewis, Eldrin F.
    Brazg, Tracy
    Martin, Mona L.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (03) : 519 - 534
  • [33] Treatment of anemia in cancer patients undergoing chemotherapy with intravenous ferric carboxymaltose without erythropoiesis-stimulating agents
    Abdel-Razeq, Hikmat
    Saadeh, Salwa S.
    Malhis, Razan
    Yasser, Sameer
    Abdulelah, Hazem
    Eljaber, Rana
    Kleib, Amer
    Ismael, Rouba
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [34] Management of anemia in low-risk myelodysplastic syndromes treated with erythropoiesis-stimulating agents newer and older agents
    Castelli, Roberto
    Schiavon, Riccardo
    Rossi, Valentina
    Deliliers, Giorgio Lambertenghi
    MEDICAL ONCOLOGY, 2018, 35 (05)
  • [35] Thrombotic Complications of Erythropoiesis-Stimulating Agents
    Lippi, Giuseppe
    Franchini, Massimo
    Favaloro, Emmanuel J.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2010, 36 (05) : 537 - 549
  • [36] Erythropoiesis-Stimulating Agents in Renal Medicine
    Locatelli, Francesco
    Del Vecchio, Lucia
    ONCOLOGIST, 2011, 16 : 19 - 24
  • [37] Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis
    Hernandez-Boluda, Juan-Carlos
    Correa, Juan-Gonzalo
    Garcia-Delgado, Regina
    Martinez-Lopez, Joaquin
    Alvarez-Larran, Alberto
    Fox, Maria-Laura
    Garcia-Gutierrez, Valentin
    Perez-Encinas, Manuel
    Ferrer-Marin, Francisca
    Mata-Vazquez, Maria-Isabel
    Raya, Jose-Maria
    Estrada, Natalia
    Garcia, Silvia
    Kerguelen, Ana
    Duran, Maria-Antonia
    Albors, Manuel
    Cervantes, Francisco
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (04) : 407 - 414
  • [38] Pharmacist collaborative practice agreement for the management of anemia in malignant disease with erythropoiesis-stimulating agents
    Weil, Elizabeth
    Oxencis, Carolyn
    SUPPORTIVE CARE IN CANCER, 2015, 23 (08) : 2507 - 2513
  • [39] Pharmacist collaborative practice agreement for the management of anemia in malignant disease with erythropoiesis-stimulating agents
    Elizabeth Weil
    Carolyn Oxencis
    Supportive Care in Cancer, 2015, 23 : 2507 - 2513
  • [40] Venous thromboembolism risk and erythropoiesis-stimulating agents for the treatment of cancer-associated anemia: a meta-analysis
    Gao, Sheng
    Ma, Jing-Jing
    Lu, Cheng
    TUMOR BIOLOGY, 2014, 35 (01) : 603 - 613
12345